Conversations in Drug Development
Episodes
How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?
10 Mar 2026
Contributed by Lukas
In this episode of Conversations in Drug Development, host Harriet Edwards is joined by Kelsey Lennoch and Eamon McGowran to discuss the EU Biotech A...
Navigating the FDA Landscape: More Changes, and What's Next?
23 Oct 2025
Contributed by Lukas
In this episode, Eric Hardter and guest Kelsey Lenoch discuss recent US FDA developments, including leadership changes at CBER and CDER, staffing impa...
At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development
26 Aug 2025
Contributed by Lukas
In this special episode of Conversations in Drug Development, host Harriet Edwards sits down with Professor Alan Boyd, founder and CEO of Boyds, t...
Navigating the New FDA Landscape: Opportunities and Challenges Ahead
15 Jul 2025
Contributed by Lukas
In the latest episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Eric Hardter discuss the ever-changing US regulatory landscape u...
From Lab to Launch – Avoiding the Pitfalls of Drug Development
29 May 2025
Contributed by Lukas
In this episode, Dr Neil Fish and Dr Ami Patel dive into the real-world challenges of drug development - from early-stage planning to regulatory hurdl...
Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025
17 Mar 2025
Contributed by Lukas
In this episode, Harriet Edwards from Boyds hosts a discussion on 2025 predictions in drug development and regulatory affairs. Joined by regulatory ex...
How to Effectively De-Risk your IND Process
11 Feb 2025
Contributed by Lukas
In this episode, Dr. Nick Meyers and Dr. Eric Hardter, discuss effective strategies for de-risking Investigational New Drug (IND) applications. Discov...
Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators
07 Jan 2025
Contributed by Lukas
In this episode, host Harriet Edwards is joined by Eamonn McGowran, an expert in medical device regulations, to explore the complex and rapidly evolvi...
Patients as Partners: Advocacy's Role in Shaping Drug Development
08 Nov 2024
Contributed by Lukas
In this episode, host Harriet Edwards and Senior Clinical Project Manager, Chris Moore, discuss the vital role of patient and public involvement in dr...
Navigating the Future of EU Health Technology Assessments
16 Oct 2024
Contributed by Lukas
In this episode, host Dr Julie Warner is joined by experts from Decisive Consulting, Esther Nzenza, and Kevin Asher to discuss the upcoming joint clin...
A Guide to Marketing Authorization Applications in Europe
24 Sep 2024
Contributed by Lukas
In this episode, host Harriet Edwards is joined by Dr Katherine Bowen to explore the regulatory fundamentals for obtaining marketing authorization in ...
Navigating the new EU Clinical Trials Regulation
13 Aug 2024
Contributed by Lukas
In this episode, host Harriet Edwards is joined by Dr Katherine Bowen and Shalini Gupta to explore the transformative changes in the European Union's ...
Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy
25 Jul 2024
Contributed by Lukas
In this episode, host Harriet Edwards is joined by two regulatory experts from Boyds, Dr Patrick Ginty and Monica Pianella, to discuss cell-based immu...
Demystifying Regulatory Designations in Drug Development
10 Jul 2024
Contributed by Lukas
In this episode, Dr Katherine Bowen and Dr Julie Warner delve into the world of regulatory designations, providing clarity on what these designations ...
Exploring Genome Editing Technologies in Drug Development
19 Jun 2024
Contributed by Lukas
In this episode, host Dr. Katherine Bowen, is joined by Harriet Edwards, Associate Director in Regulatory Affairs, to explore the fascinating world of...
The Most Essential Tips for Biotechs Seeking Investment
03 Jun 2024
Contributed by Lukas
Welcome to a special edition of Conversations in Drug Development, brought to you by the team at Boyds. In this episode, our host Harriet Edwards ha...
The Use of ATMPs in Oncology Clinical Trials
21 May 2024
Contributed by Lukas
How can phase I studies with ATMPs address unmet needs in oncology and what are the challenges? In this episode of Conversations in Drug Development, ...
How are GMO Regulations Impacting Clinical Development in Europe?
25 Apr 2024
Contributed by Lukas
In this episode of Conversations in Drug Development, our host Harriet Edwards, is joined by Director of Regulatory Affairs, Dr Sabine Ruehle, to disc...
US Drug Development: The Latest Regulatory Trends and Initiatives
19 Mar 2024
Contributed by Lukas
In this episode of Conversations in Drug Development, host Dr Harriet Edwards is joined by Katy Rudnick and Dr Julie Warner from Boyds to discuss US r...
The Regulatory Challenges of Rare Disease Drug Development
28 Feb 2024
Contributed by Lukas
To celebrate Rare Disease Day, we are back with another Conversation in Drug Development, this time discussing the unique challenges of rare disease d...
The Drug Development Landscape: Trends and Predictions for 2024
22 Jan 2024
Contributed by Lukas
We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host...
Off-the-Shelf Cell Therapies: Breaking Barriers and Revolutionizing Patient Care
04 Dec 2023
Contributed by Lukas
In this episode of "Conversations in Drug Development", Harriet Edwards and Dr. Patrick Ginty discuss off-the-shelf cell therapies, explaining how the...
The Future of Drug Development: AI’s Role in Revolutionizing the Industry
08 Nov 2023
Contributed by Lukas
In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence...
Recent Trends in Oncology Drug Development
04 Oct 2023
Contributed by Lukas
In this episode, Dr Katherine Bowen and Dr Julie Warner delve deep into the ever-evolving world of oncology drug development and the regulatory landsc...